InsidersTradesSigma
CalciMedica, Inc. Stock: price and directors' dealings · United States · SEC (Form 4)
Follow the CalciMedica, Inc. share price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Market capitalisation: €15m. The latest transaction was reported on 29 June 2026 (Attribution). Among the most active insiders: Roberts Eric W. Every trade is openly available.
96
Insider Decl.
n/a
Thresholds
€3m
77 ops.
Buy Volume
€3,105
9 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate CalciMedica, Inc. Buy (bullish), based on 2 analysts. Average price target: US$10.50.
46Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 29 June 2026
Declarations96 total
1,182,621 sharesCommon StockSEC:0001189022-26-000002:0
248,972 sharesCommon StockSEC:0001267959-26-000003:0
Canonical exit: 23 Sept 2026 (T+90)
186,729 sharesCommon StockSEC:0001484729-26-000004:0
186,729 sharesCommon StockSEC:0001576244-26-000004:0
124,486 sharesCommon StockSEC:0001968793-26-000004:0
2,500 shares@ US$3.07Common StockSEC:0001576244-25-000007:0
Canonical exit: 17 Dec 2025 (T+90)
3,400 shares@ US$2.6779Common StockSEC:0001576244-25-000005:0
Canonical exit: 14 Dec 2025 (T+90)
5,000 shares@ US$3.121.6% of flowCommon StockSEC:0001576244-25-000003:0
Canonical exit: 11 Dec 2025 (T+90)
2,343 shares@ US$3.14880.8% of flowCommon StockSEC:0001415889-25-024256:0
Canonical exit: 8 Dec 2025 (T+90)
9,200 shares@ US$2.8632.9% of flowCommon StockSEC:0001415889-25-023364:0
Canonical exit: 26 Nov 2025 (T+90)
3,508 shares@ US$2.79281.1% of flowCommon StockSEC:0001415889-25-022850:0
Canonical exit: 19 Nov 2025 (T+90)
1,000 shares@ US$2.790.3% of flowCommon StockSEC:0001415889-25-022550:0
Canonical exit: 17 Nov 2025 (T+90)
9,563 shares@ US$2.819416.0% of flowCommon StockSEC:0001415889-25-022549:0
Canonical exit: 17 Nov 2025 (T+90)
5,076 shares@ US$2.89771.6% of flowCommon StockSEC:0001415889-25-022261:0
Canonical exit: 13 Nov 2025 (T+90)
1,584 shares@ US$2.5852.9% of flowCommon StockSEC:0001415889-25-022159:0
Canonical exit: 12 Nov 2025 (T+90)
1,000 shares@ US$3.6566.5% of flowCommon StockSEC:0001415889-25-020458:0
1,500 shares@ US$3.7750.6% of flowCommon StockSEC:0001415889-25-020164:0
Canonical exit: 20 Oct 2025 (T+90)
1,500 shares@ US$3.370.6% of flowCommon StockSEC:0001415889-25-020111:0
Canonical exit: 19 Oct 2025 (T+90)
1,000 shares@ US$3.400.6% of flowCommon StockSEC:0001415889-25-020052:0
Canonical exit: 19 Oct 2025 (T+90)
4,500 shares@ US$2.871.3% of flowCommon StockSEC:0001415889-25-019998:0
Canonical exit: 16 Oct 2025 (T+90)
2,000 shares@ US$2.880.7% of flowCommon StockSEC:0001415889-25-019997:0
Canonical exit: 16 Oct 2025 (T+90)
6,500 shares@ US$2.43231.8% of flowCommon StockSEC:0001415889-25-019822:0
Canonical exit: 12 Oct 2025 (T+90)
2,500 shares@ US$2.471.1% of flowCommon StockSEC:0001415889-25-019816:0
Canonical exit: 12 Oct 2025 (T+90)
5,000 shares@ US$1.60470.9% of flowCommon StockSEC:0001415889-25-019655:0
Canonical exit: 7 Oct 2025 (T+90)
1,000 shares@ US$1.85100.0% of flowCommon StockSEC:0001415889-25-019190:0
Canonical exit: 29 Sept 2025 (T+90)
25 of 96 declarations
About CalciMedica, Inc.
CalciMedica, Inc. is a biopharmaceutical company focused on developing treatments for diseases related to calcium regulation. It is listed on NASDAQ under the ticker XNAS.